Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds

Heart

Volumn 100, Issue 23, 2014, Pages 1825-1830

  Muylaert, Dimitri E P ^a   Fledderus, Joost O ^a   Bouten, Carlijn V C ^b   Dankers, Patricia Y W ^b   Verhaar, Marianne C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTEGRIN; INTERLEUKIN 10; MACROPHAGE CHEMOTACTIC FACTOR; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR B; STROMAL CELL DERIVED FACTOR 1ALPHA; BIOLOGICAL MARKER;

BIOLOGICAL ACTIVITY; CELL FREE SYSTEM; CELL FREE VASCULAR SCAFFOLD; CELL HOMING; CORONARY ARTERY BYPASS GRAFT; COVALENT BOND; CYTOKINE RELEASE; DRUG DELIVERY DEVICE; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; HEART MUSCLE ISCHEMIA; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; MATERIALS TESTING; MECHANICAL STIMULATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE ABILITY; REVIEW; STEM CELL MOBILIZATION; STIMULUS RESPONSE; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REPAIR; TISSUE SCAFFOLD; ANIMAL; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; CONVALESCENCE; CORONARY ARTERY DISEASE; DEVICES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL MARKERS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERY DISEASE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84922393721     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306092     Document Type: Review

References (29)

1. Shirozu M, Nakano T, Inazawa J, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995;28:495-500.
2. van Oostrom O, Fledderus J, de Kleijn D, et al. Smooth muscle progenitor cells: friend or foe in vascular disease. Curr Stem Cell Res Ther 2009;4:131-40.
3. Xu X, Zhu F, Zhang M, et al. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs (Print) 2013;197:103-13.
4. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008;45:514-22.
5. Chavakis E, Dimmeler S. Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal 2011;15:967-80.
6. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625-37.
7. Morris LM, Klanke CA, Lang SA, et al. Characterization of endothelial progenitor cells mobilization following cutaneous wounding. Wound Repair Regen 2010;18:383-90.
8. Yu S, Crawford D, Tsuchihashi T, et al. The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn 2011;240:384-93.
9. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012;148:399-408.
10. Vanden Berg-Foels WS. In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev 2014;20:28-39.
11. Zaruba M-M, Franz W-M. Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opin Biol Ther 2010;10:321-35. http://wwwexpertopincom/ebt
12. Zamilpa R, Lindsey ML. Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. J Mol Cell Cardiol 2010;48:558-63.
13. Artlett CM. Inflammasomes in wound healing and fibrosis. J Pathol 2013;229:157-67.
14. Baay-Guzman GJ, Bebenek IG, Zeidler M, et al. HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation. Respir Res 2012;13:60.
15. Koenig GC, Rowe RG, Day SM, et al. MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction. Am J Pathol 2012;180:1863-78.
16. Sharma M, Afrin F, Satija N, et al. Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 2011;20:933-46.
17. Arthur A, Shi S, Zannettino ACW, et al. Implanted adult human dental pulp stem cells induce endogenous axon guidance. Stem Cells 2009;27:2229-37.
18. Ghadge SK, Mühlstedt S, Özcelik C, et al. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 2011;129:97-108.
19. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122:787-95.
20. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845-8.
21. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 2011;89:557-63.
22. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011;12:1035-44.
23. Ploeger DT, Hosper NA, Schipper M, et al. Cell plasticity in wound healing: paracrine factors of M1/ M2 polarized macrophages influence the phenotypical state of dermal fibroblasts. Cell Commun Signal 2013;11:29.
24. Chen C-W, Okada M, Proto JD, et al. Human pericytes for ischemic heart repair. Stem Cells 2013;31:305-16.
25. Sanchez-Martin L, Estecha A, Samaniego R, et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 2011;117:88-97.
26. Sheng J, Cai W-W, Fang N-Y, et al. Role of stromal-derived factor-1/CXCR4 in neo-intimal repair. Cardiovasc J Afr 2011;22:313-8.
27. Kurobe H, Maxfield MW, Breuer CK, et al. Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future. Stem Cells Transl Med 2012;1:566-71.
28. Min B-J, Kim YJ, Choi J-W, et al. Histologic characteristics and mechanical properties of bovine pericardium treated with decellularization and α-galactosidase: a comparative study. Korean J Thorac Cardiovasc Surg 2012;45:368-79.
29. Kanie K, Narita Y, Zhao Y, et al. Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells. Biotechnol Bioeng 2012;109:1808-16.